Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yehenew A, Ebstie"'
Autor:
Abdollah Jalilian, Galana Mamo Ayana, Temesgen Ashine, Elifaged Hailemeskel, Yehenew Asmamaw Ebstie, Eshetu Molla, Endashaw Esayas, Nigatu Negash, Abena Kochora, Muluken Assefa, Natnael Teferi, Daniel Teshome, Alison M. Reynolds, David Weetman, Anne L. Wilson, Birhanu Kenate, Martin J. Donnelly, Luigi Sedda, Endalamaw Gadisa
Publikováno v:
Infectious Diseases of Poverty, Vol 13, Iss 1, Pp 1-12 (2024)
Abstract Background Despite consecutive decades of success in reducing malaria transmission, Ethiopia went off track towards its goal of malaria elimination by 2030, as outlined in the NMCP malaria strategy. Recent malaria outbreaks in Ethiopia are a
Externí odkaz:
https://doaj.org/article/44ac0cb2407b4ce0b810aaae7bbcdc43
Autor:
Temesgen Ashine, Yehenew Asmamaw Ebstie, Rayyan Ibrahim, Adrienne Epstein, John Bradley, Mujahid Nouredayem, Mikiyas G Michael, Amani Sidiahmed, Nigatu Negash, Abena Kochora, Jihad Eltaher Sulieman, Alison M Reynolds, Eba Alemayehu, Endalew Zemene, Adane Eyasu, Alemayehu Dagne, Elifaged Hailemeskel, Fatou Jaiteh, Dereje Geleta, Ephrem Lejore, David Weetman, Ahmed Mahmoud Hussien, Fadwa Saad, Gudissa Assefa, Hiwot Solomon, Abdelgadir Bashir, Fekadu Massebo, Koen Peeters, Delenasaw Yewhalaw, Hmooda Toto Kafy, Martin J Donnelly, Endalamaw Gadisa, Elfatih M Malik, Anne L Wilson
Publikováno v:
PLoS ONE, Vol 19, Iss 9, p e0309058 (2024)
BackgroundEndemic African malaria vectors are poorly adapted to typical urban ecologies. However, Anopheles stephensi, an urban malaria vector formerly confined to South Asia and the Persian Gulf, was recently detected in Africa and may change the ep
Externí odkaz:
https://doaj.org/article/25b2acbc0a264fa9af3b93f3db04b11f
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161483 (2016)
BACKGROUND:Resistance to anti-malarials is a major challenge for effective malaria control in sub-Saharan Africa. This triggered a need for routine monitoring of the efficacy of the antimalarial drugs every two years in all malaria endemic countries.
Externí odkaz:
https://doaj.org/article/b2496a50e49e4006b72f7e00d187e7b0
Autor:
Yehenew A. Ebstie, Alain R Tenoh Guedoung, Annette Habluetzel, Shaaban J. Katani, Hamisi M. Malebo, Harouna Soré, Donatella Taramelli, Silvia Parapini, Sarah D'Alessandro
Publikováno v:
Drug Design, Development and Therapy. 14:1593-1607
Purpose Continuous efforts into the discovery and development of new antimalarials are required to face the emerging resistance of the parasite to available treatments. Thus, new effective drugs, ideally able to inhibit the Plasmodium life-cycle stag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7516f1b3ddceff5d4e72a6cac66937dc
https://doi.org/10.2147/dddt.s242883
https://doi.org/10.2147/dddt.s242883
Publikováno v:
MalariaWorld Journal
Background Current efforts towards malaria elimination include the discovery of new transmission blocking (TB) drugs and identification of compounds suitable to replace primaquine, recommended as transmission blocking post treatment after artemisinin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6e9796ddb67baf0639238e2ec7ef58c6
http://europepmc.org/articles/PMC8415060
http://europepmc.org/articles/PMC8415060
Autor:
Alain R Tenoh Guedoung, Yehenew A. Ebstie, Annette Habluetzel, Adama Hilou, Anake Kijjoa, José Alberto Pereira, Harouna Soré, Annalisa Lopatriello, Orazio Taglialatela-Scafati
Targeting the transmissible stages of the Plasmodium parasite that develop in the human and mosquito host is a crucial strategy for malaria control and elimination. Medicinal plants offer a prolific source for the discovery of new antimalarial compou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818c4986129b4e7b7d9ab17a6b494379
http://hdl.handle.net/11581/447810
http://hdl.handle.net/11581/447810
Publikováno v:
Drug Design, Development and Therapy. 10:2387-2399
Despite declining global malaria incidence, the disease continues to be a threat to people living in endemic regions. In 2015, an estimated 214 million new malaria cases and 438,000 deaths due to malaria were recorded. Plasmodium vivax is the second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62774a1c2ef3a78b96739fc53140db83
https://doi.org/10.2147/dddt.s61443
https://doi.org/10.2147/dddt.s61443
Publikováno v:
Drug Design, Development and Therapy
Despite declining global malaria incidence, the disease continues to be a threat to people living in endemic regions. In 2015, an estimated 214 million new malaria cases and 438,000 deaths due to malaria were recorded. Plasmodium vivax is the second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ad2bdc336d1903bb09f070e662ae0be6
https://pubmed.ncbi.nlm.nih.gov/27528800
https://pubmed.ncbi.nlm.nih.gov/27528800
Publikováno v:
European Journal of Medical Research
Background Hepatitis, a highly contagious viral infection, is one of the leading killer diseases globally caused by hepatitis virus. Among the existing viral causes for hepatic failure, hepatitis B virus (HBV) plays a significant role with devastatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f818a36bb2f90371896ca394f19a6af
http://europepmc.org/articles/PMC4831185
http://europepmc.org/articles/PMC4831185
Publikováno v:
Malaria Journal
Background Malaria is a complex disease, which varies in its epidemiology and clinical manifestation. Although artemether-lumefantrine has been used as first-line drug for uncomplicated Plasmodium falciparum malaria in Bahir Dar district since 2004,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e591ce93de48d03947c7e7bc73ab510c
https://doi.org/10.1186/s12936-015-0744-x
https://doi.org/10.1186/s12936-015-0744-x